Immix Biopharma Inc (IMMX)

Name: Immix Biopharma Inc (IMMX) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Immix Biopharma Inc (IMMX)

Stock Card

$14.22

$0.19 (1.33%)

As on 01-Sep-2026 13:37EDT

Market cap

$992 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

4.4

Div. Yield

0 %

Immix Biopharma Inc (IMMX) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 13.62 High: 14.24

52 Week Range

Low: 1.94 High: 15.10

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.3 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-0.4
Debt to Equity

0
Book Value

$--
EPS

$-0.9
Face value

--
Shares outstanding

71,189,951

5 Years Aggregate

CFO

$-21.56 Mln

EBITDA

$-26.99 Mln

Net Profit

$-50.16 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Immix Biopharma Inc (IMMX)	171.8	70.9	58.0	540.4	91.3	--	--
BSE Sensex	-9.1	-1.5	2.9	-3.6	5.9	6.0	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 01-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023
Immix Biopharma Inc (IMMX)	137.7	-67.9	202.2
S&P Small-Cap 600	4.0	7.0	13.9
BSE Sensex	9.1	8.1	18.7

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Immix Biopharma Inc (IMMX)	14.2	992.4	0.0	-39.9	--	-24.7	--	4.4
Arrowhead Pharmaceuticals (ARWR)	82.8	11,993.9	669.5	-320.0	-0.8	-71.1	--	26.9
Cytokinetics Inc (CYTK)	71.7	10,022.2	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	55.8	13,491.7	2,435.9	860.6	31.0	43	17.4	7.4
Halozyme Therapeutics (HALO)	107.7	11,957.0	1,663.7	413.6	36.3	430	30.9	84.5
Krystal Biotech (KRYS)	361.3	10,402.8	440.5	241.5	33.4	18.7	44.1	7.8
Madrigal Pharmaceuticals (MDGL)	536.6	12,332.1	1,283.9	-325.1	-19.0	-57.7	--	24.0
Medpace Holdings (MEDP)	587.1	16,765.1	2,782.3	491.5	21.1	110.1	35.2	39.3
Praxis Precision MedicinesÂ Inc (PRAX)	350.0	9,625.4	0.0	-339.1	--	-30.6	--	7.6
Protagonist Therapeutics (PTGX)	146.8	9,339.4	282.0	82.9	-28.6	11.4	140.1	11.5

Shareholding Pattern

View Details

About Immix Biopharma Inc (IMMX)

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead... product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California. Read more

Co-Founder, CEO & Chairman

Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Co-Founder, CEO & Chairman

Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Headquarters

Los Angeles, CA
Website

https://www.immixbio.com

FAQs for Immix Biopharma Inc (IMMX)

What is the current share price of Immix Biopharma Inc (IMMX) Today?

The share price of Immix Biopharma Inc (IMMX) is $14.22 (NASDAQ) as of 01-Sep-2026 13:37 EDT. Immix Biopharma Inc (IMMX) has given a return of 91.32% in the last 3 years.

What is the current PB & PE ratio of Immix Biopharma Inc (IMMX)?

Since, TTM earnings of Immix Biopharma Inc (IMMX) is negative, P/E ratio is not available.
The P/B ratio of Immix Biopharma Inc (IMMX) is 4.45 times as on 28-Aug-2026, a 14 discount to its peers’ median range of 5.18 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-6.80	2.13
2024	-2.80	4.57
2023	-8.94	8.40
2022	-3.68	2.30
2021	-1.11	1.50

What is the 52 Week High and Low of Immix Biopharma Inc (IMMX)?

The 52-week high and low of Immix Biopharma Inc (IMMX) are Rs 15.10 and Rs 1.94 as of 02-Sep-2026.

What is the market cap of Immix Biopharma Inc (IMMX)?

Immix Biopharma Inc (IMMX) has a market capitalisation of $ 992 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Immix Biopharma Inc (IMMX)?

Before investing in Immix Biopharma Inc (IMMX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.